nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—HRH1—atherosclerosis	0.448	1	CbGaD
Loratadine—CYP2C8—Simvastatin—atherosclerosis	0.0278	0.0632	CbGbCtD
Loratadine—CYP2C8—Pravastatin—atherosclerosis	0.0272	0.0618	CbGbCtD
Loratadine—CYP2C8—Lovastatin—atherosclerosis	0.0272	0.0618	CbGbCtD
Loratadine—CYP2C19—Rosuvastatin—atherosclerosis	0.0251	0.057	CbGbCtD
Loratadine—CYP2C19—Simvastatin—atherosclerosis	0.0233	0.053	CbGbCtD
Loratadine—CYP2C19—Lovastatin—atherosclerosis	0.0228	0.0519	CbGbCtD
Loratadine—CYP2D6—Niacin—atherosclerosis	0.0224	0.051	CbGbCtD
Loratadine—CYP2C9—Rosuvastatin—atherosclerosis	0.0209	0.0474	CbGbCtD
Loratadine—ABCB1—Ezetimibe—atherosclerosis	0.0202	0.046	CbGbCtD
Loratadine—CYP2C9—Simvastatin—atherosclerosis	0.0194	0.0441	CbGbCtD
Loratadine—CYP2C9—Pravastatin—atherosclerosis	0.019	0.0431	CbGbCtD
Loratadine—CYP2C9—Lovastatin—atherosclerosis	0.019	0.0431	CbGbCtD
Loratadine—ABCB1—Simvastatin—atherosclerosis	0.0188	0.0428	CbGbCtD
Loratadine—ABCB1—Pravastatin—atherosclerosis	0.0184	0.0419	CbGbCtD
Loratadine—ABCB1—Lovastatin—atherosclerosis	0.0184	0.0419	CbGbCtD
Loratadine—CYP2D6—Simvastatin—atherosclerosis	0.0177	0.0403	CbGbCtD
Loratadine—CYP2D6—Pravastatin—atherosclerosis	0.0173	0.0394	CbGbCtD
Loratadine—CYP2D6—Lovastatin—atherosclerosis	0.0173	0.0394	CbGbCtD
Loratadine—CYP3A4—Rosuvastatin—atherosclerosis	0.0121	0.0276	CbGbCtD
Loratadine—CYP3A4—Ezetimibe—atherosclerosis	0.0121	0.0276	CbGbCtD
Loratadine—CYP3A4—Simvastatin—atherosclerosis	0.0113	0.0256	CbGbCtD
Loratadine—CYP3A4—Lovastatin—atherosclerosis	0.011	0.0251	CbGbCtD
Loratadine—CYP3A4—Pravastatin—atherosclerosis	0.011	0.0251	CbGbCtD
Loratadine—Alcaftadine—HRH1—atherosclerosis	0.00217	0.416	CrCbGaD
Loratadine—Drug interaction—Rosuvastatin—atherosclerosis	0.00151	0.0178	CcSEcCtD
Loratadine—Nightmare—Rosuvastatin—atherosclerosis	0.00135	0.0159	CcSEcCtD
Loratadine—Viral infection—Ezetimibe—atherosclerosis	0.00129	0.0152	CcSEcCtD
Loratadine—Drug interaction—Ezetimibe—atherosclerosis	0.00126	0.0148	CcSEcCtD
Loratadine—Drug interaction—Simvastatin—atherosclerosis	0.0012	0.0141	CcSEcCtD
Loratadine—Desloratadine—HRH1—atherosclerosis	0.00119	0.228	CrCbGaD
Loratadine—Viral infection—Pravastatin—atherosclerosis	0.00111	0.0131	CcSEcCtD
Loratadine—Drug interaction—Pravastatin—atherosclerosis	0.00108	0.0127	CcSEcCtD
Loratadine—Nightmare—Simvastatin—atherosclerosis	0.00107	0.0126	CcSEcCtD
Loratadine—Azatadine—HRH1—atherosclerosis	0.000995	0.191	CrCbGaD
Loratadine—Nightmare—Pravastatin—atherosclerosis	0.00097	0.0114	CcSEcCtD
Loratadine—Ketotifen—HRH1—atherosclerosis	0.000863	0.166	CrCbGaD
Loratadine—Depression—Rosuvastatin—atherosclerosis	0.000782	0.0092	CcSEcCtD
Loratadine—Dermatitis bullous—Niacin—atherosclerosis	0.000775	0.00912	CcSEcCtD
Loratadine—Gastritis—Ezetimibe—atherosclerosis	0.000749	0.00881	CcSEcCtD
Loratadine—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.000742	0.00873	CcSEcCtD
Loratadine—Gastritis—Simvastatin—atherosclerosis	0.000714	0.0084	CcSEcCtD
Loratadine—Pharyngitis—Rosuvastatin—atherosclerosis	0.000699	0.00822	CcSEcCtD
Loratadine—Arrhythmia—Rosuvastatin—atherosclerosis	0.000629	0.0074	CcSEcCtD
Loratadine—Depression—Simvastatin—atherosclerosis	0.00062	0.00729	CcSEcCtD
Loratadine—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000617	0.00725	CcSEcCtD
Loratadine—Pharyngitis—Ezetimibe—atherosclerosis	0.000581	0.00683	CcSEcCtD
Loratadine—Depression—Pravastatin—atherosclerosis	0.000561	0.00659	CcSEcCtD
Loratadine—Angioedema—Rosuvastatin—atherosclerosis	0.00056	0.00659	CcSEcCtD
Loratadine—Cough—Rosuvastatin—atherosclerosis	0.000535	0.00629	CcSEcCtD
Loratadine—Immune system disorder—Ezetimibe—atherosclerosis	0.000529	0.00622	CcSEcCtD
Loratadine—Alopecia—Lovastatin—atherosclerosis	0.000527	0.0062	CcSEcCtD
Loratadine—Myalgia—Rosuvastatin—atherosclerosis	0.000522	0.00614	CcSEcCtD
Loratadine—Alopecia—Ezetimibe—atherosclerosis	0.000517	0.00608	CcSEcCtD
Loratadine—Dysgeusia—Lovastatin—atherosclerosis	0.000509	0.00598	CcSEcCtD
Loratadine—Pharyngitis—Pravastatin—atherosclerosis	0.000501	0.00589	CcSEcCtD
Loratadine—Alopecia—Simvastatin—atherosclerosis	0.000493	0.0058	CcSEcCtD
Loratadine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000491	0.00577	CcSEcCtD
Loratadine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000482	0.00567	CcSEcCtD
Loratadine—Tinnitus—Niacin—atherosclerosis	0.000478	0.00562	CcSEcCtD
Loratadine—Dysgeusia—Simvastatin—atherosclerosis	0.000476	0.0056	CcSEcCtD
Loratadine—Angioedema—Lovastatin—atherosclerosis	0.000475	0.00558	CcSEcCtD
Loratadine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000473	0.00556	CcSEcCtD
Loratadine—Tinnitus—Pravastatin—atherosclerosis	0.000471	0.00553	CcSEcCtD
Loratadine—Malaise—Lovastatin—atherosclerosis	0.000468	0.00551	CcSEcCtD
Loratadine—Angioedema—Ezetimibe—atherosclerosis	0.000466	0.00548	CcSEcCtD
Loratadine—Malaise—Ezetimibe—atherosclerosis	0.000459	0.00541	CcSEcCtD
Loratadine—Arrhythmia—Niacin—atherosclerosis	0.000458	0.00539	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000456	0.00536	CcSEcCtD
Loratadine—Alopecia—Niacin—atherosclerosis	0.000453	0.00533	CcSEcCtD
Loratadine—Insomnia—Rosuvastatin—atherosclerosis	0.000452	0.00532	CcSEcCtD
Loratadine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000451	0.0053	CcSEcCtD
Loratadine—Arrhythmia—Pravastatin—atherosclerosis	0.000451	0.0053	CcSEcCtD
Loratadine—Palpitations—Ezetimibe—atherosclerosis	0.00045	0.0053	CcSEcCtD
Loratadine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000449	0.00528	CcSEcCtD
Loratadine—Alopecia—Pravastatin—atherosclerosis	0.000446	0.00525	CcSEcCtD
Loratadine—Cough—Ezetimibe—atherosclerosis	0.000445	0.00523	CcSEcCtD
Loratadine—Angioedema—Simvastatin—atherosclerosis	0.000444	0.00522	CcSEcCtD
Loratadine—Myalgia—Lovastatin—atherosclerosis	0.000442	0.0052	CcSEcCtD
Loratadine—Chest pain—Lovastatin—atherosclerosis	0.000442	0.0052	CcSEcCtD
Loratadine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00044	0.00518	CcSEcCtD
Loratadine—Hypertension—Ezetimibe—atherosclerosis	0.00044	0.00517	CcSEcCtD
Loratadine—Malaise—Simvastatin—atherosclerosis	0.000438	0.00515	CcSEcCtD
Loratadine—Tension—Niacin—atherosclerosis	0.000438	0.00515	CcSEcCtD
Loratadine—Discomfort—Lovastatin—atherosclerosis	0.000437	0.00514	CcSEcCtD
Loratadine—Chest pain—Ezetimibe—atherosclerosis	0.000434	0.0051	CcSEcCtD
Loratadine—Myalgia—Ezetimibe—atherosclerosis	0.000434	0.0051	CcSEcCtD
Loratadine—Nervousness—Niacin—atherosclerosis	0.000433	0.0051	CcSEcCtD
Loratadine—Dry mouth—Lovastatin—atherosclerosis	0.000433	0.00509	CcSEcCtD
Loratadine—Tension—Pravastatin—atherosclerosis	0.000431	0.00507	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000431	0.00507	CcSEcCtD
Loratadine—Dysgeusia—Pravastatin—atherosclerosis	0.00043	0.00506	CcSEcCtD
Loratadine—Discomfort—Ezetimibe—atherosclerosis	0.000429	0.00504	CcSEcCtD
Loratadine—Constipation—Rosuvastatin—atherosclerosis	0.000428	0.00503	CcSEcCtD
Loratadine—Pain—Rosuvastatin—atherosclerosis	0.000428	0.00503	CcSEcCtD
Loratadine—Nervousness—Pravastatin—atherosclerosis	0.000427	0.00502	CcSEcCtD
Loratadine—Dry mouth—Ezetimibe—atherosclerosis	0.000424	0.00499	CcSEcCtD
Loratadine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000424	0.00499	CcSEcCtD
Loratadine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000416	0.00489	CcSEcCtD
Loratadine—Chest pain—Simvastatin—atherosclerosis	0.000414	0.00487	CcSEcCtD
Loratadine—Myalgia—Simvastatin—atherosclerosis	0.000414	0.00487	CcSEcCtD
Loratadine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000412	0.00485	CcSEcCtD
Loratadine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000409	0.00481	CcSEcCtD
Loratadine—Discomfort—Simvastatin—atherosclerosis	0.000409	0.00481	CcSEcCtD
Loratadine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000408	0.0048	CcSEcCtD
Loratadine—Angioedema—Niacin—atherosclerosis	0.000408	0.0048	CcSEcCtD
Loratadine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000408	0.00479	CcSEcCtD
Loratadine—Skin disorder—Ezetimibe—atherosclerosis	0.000404	0.00475	CcSEcCtD
Loratadine—Angioedema—Pravastatin—atherosclerosis	0.000401	0.00472	CcSEcCtD
Loratadine—Syncope—Niacin—atherosclerosis	0.0004	0.00471	CcSEcCtD
Loratadine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000397	0.00467	CcSEcCtD
Loratadine—Malaise—Pravastatin—atherosclerosis	0.000396	0.00466	CcSEcCtD
Loratadine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000395	0.00465	CcSEcCtD
Loratadine—Palpitations—Niacin—atherosclerosis	0.000394	0.00464	CcSEcCtD
Loratadine—Loss of consciousness—Niacin—atherosclerosis	0.000392	0.00461	CcSEcCtD
Loratadine—Cough—Niacin—atherosclerosis	0.000389	0.00458	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000386	0.00454	CcSEcCtD
Loratadine—Insomnia—Lovastatin—atherosclerosis	0.000383	0.00451	CcSEcCtD
Loratadine—Cough—Pravastatin—atherosclerosis	0.000383	0.00451	CcSEcCtD
Loratadine—Paraesthesia—Lovastatin—atherosclerosis	0.000381	0.00448	CcSEcCtD
Loratadine—Myalgia—Niacin—atherosclerosis	0.00038	0.00447	CcSEcCtD
Loratadine—Hypertension—Pravastatin—atherosclerosis	0.000379	0.00446	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000379	0.00446	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000377	0.00444	CcSEcCtD
Loratadine—Insomnia—Ezetimibe—atherosclerosis	0.000376	0.00442	CcSEcCtD
Loratadine—Chest pain—Pravastatin—atherosclerosis	0.000374	0.0044	CcSEcCtD
Loratadine—Myalgia—Pravastatin—atherosclerosis	0.000374	0.0044	CcSEcCtD
Loratadine—Paraesthesia—Ezetimibe—atherosclerosis	0.000373	0.00439	CcSEcCtD
Loratadine—Dyspepsia—Lovastatin—atherosclerosis	0.000373	0.00439	CcSEcCtD
Loratadine—Dry mouth—Niacin—atherosclerosis	0.000371	0.00437	CcSEcCtD
Loratadine—Discomfort—Pravastatin—atherosclerosis	0.00037	0.00435	CcSEcCtD
Loratadine—Dyspepsia—Ezetimibe—atherosclerosis	0.000366	0.00431	CcSEcCtD
Loratadine—Fatigue—Lovastatin—atherosclerosis	0.000366	0.0043	CcSEcCtD
Loratadine—Anaphylactic shock—Niacin—atherosclerosis	0.000364	0.00428	CcSEcCtD
Loratadine—Constipation—Lovastatin—atherosclerosis	0.000363	0.00426	CcSEcCtD
Loratadine—Pain—Lovastatin—atherosclerosis	0.000363	0.00426	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000361	0.00425	CcSEcCtD
Loratadine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000359	0.00422	CcSEcCtD
Loratadine—Asthenia—Rosuvastatin—atherosclerosis	0.000359	0.00422	CcSEcCtD
Loratadine—Insomnia—Simvastatin—atherosclerosis	0.000359	0.00422	CcSEcCtD
Loratadine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000359	0.00422	CcSEcCtD
Loratadine—Fatigue—Ezetimibe—atherosclerosis	0.000359	0.00422	CcSEcCtD
Loratadine—Shock—Niacin—atherosclerosis	0.000358	0.00421	CcSEcCtD
Loratadine—Paraesthesia—Simvastatin—atherosclerosis	0.000356	0.00419	CcSEcCtD
Loratadine—Pain—Ezetimibe—atherosclerosis	0.000356	0.00418	CcSEcCtD
Loratadine—Constipation—Ezetimibe—atherosclerosis	0.000356	0.00418	CcSEcCtD
Loratadine—Tachycardia—Niacin—atherosclerosis	0.000355	0.00418	CcSEcCtD
Loratadine—Skin disorder—Niacin—atherosclerosis	0.000354	0.00416	CcSEcCtD
Loratadine—Feeling abnormal—Lovastatin—atherosclerosis	0.000349	0.00411	CcSEcCtD
Loratadine—Dyspepsia—Simvastatin—atherosclerosis	0.000349	0.00411	CcSEcCtD
Loratadine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000347	0.00408	CcSEcCtD
Loratadine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000343	0.00403	CcSEcCtD
Loratadine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000342	0.00403	CcSEcCtD
Loratadine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000342	0.00403	CcSEcCtD
Loratadine—Fatigue—Simvastatin—atherosclerosis	0.000342	0.00402	CcSEcCtD
Loratadine—Hypotension—Niacin—atherosclerosis	0.00034	0.004	CcSEcCtD
Loratadine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00034	0.004	CcSEcCtD
Loratadine—Constipation—Simvastatin—atherosclerosis	0.000339	0.00399	CcSEcCtD
Loratadine—Pain—Simvastatin—atherosclerosis	0.000339	0.00399	CcSEcCtD
Loratadine—Abdominal pain—Lovastatin—atherosclerosis	0.000335	0.00394	CcSEcCtD
Loratadine—Body temperature increased—Lovastatin—atherosclerosis	0.000335	0.00394	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000332	0.0039	CcSEcCtD
Loratadine—Dizziness—Rosuvastatin—atherosclerosis	0.000331	0.00389	CcSEcCtD
Loratadine—Insomnia—Niacin—atherosclerosis	0.000329	0.00387	CcSEcCtD
Loratadine—Abdominal pain—Ezetimibe—atherosclerosis	0.000329	0.00387	CcSEcCtD
Loratadine—Body temperature increased—Ezetimibe—atherosclerosis	0.000329	0.00387	CcSEcCtD
Loratadine—Paraesthesia—Niacin—atherosclerosis	0.000327	0.00385	CcSEcCtD
Loratadine—Feeling abnormal—Simvastatin—atherosclerosis	0.000327	0.00384	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000327	0.00384	CcSEcCtD
Loratadine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000324	0.00381	CcSEcCtD
Loratadine—Insomnia—Pravastatin—atherosclerosis	0.000324	0.00381	CcSEcCtD
Loratadine—Somnolence—Niacin—atherosclerosis	0.000324	0.00381	CcSEcCtD
Loratadine—Paraesthesia—Pravastatin—atherosclerosis	0.000322	0.00379	CcSEcCtD
Loratadine—Dyspepsia—Niacin—atherosclerosis	0.000321	0.00377	CcSEcCtD
Loratadine—Dyspepsia—Pravastatin—atherosclerosis	0.000316	0.00371	CcSEcCtD
Loratadine—Rash—Rosuvastatin—atherosclerosis	0.000315	0.00371	CcSEcCtD
Loratadine—Dermatitis—Rosuvastatin—atherosclerosis	0.000315	0.00371	CcSEcCtD
Loratadine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000314	0.0037	CcSEcCtD
Loratadine—Body temperature increased—Simvastatin—atherosclerosis	0.000313	0.00369	CcSEcCtD
Loratadine—Abdominal pain—Simvastatin—atherosclerosis	0.000313	0.00369	CcSEcCtD
Loratadine—Headache—Rosuvastatin—atherosclerosis	0.000313	0.00369	CcSEcCtD
Loratadine—Pain—Niacin—atherosclerosis	0.000311	0.00366	CcSEcCtD
Loratadine—Fatigue—Pravastatin—atherosclerosis	0.000309	0.00364	CcSEcCtD
Loratadine—Pain—Pravastatin—atherosclerosis	0.000307	0.00361	CcSEcCtD
Loratadine—Constipation—Pravastatin—atherosclerosis	0.000307	0.00361	CcSEcCtD
Loratadine—Asthenia—Lovastatin—atherosclerosis	0.000304	0.00358	CcSEcCtD
Loratadine—Asthenia—Ezetimibe—atherosclerosis	0.000298	0.00351	CcSEcCtD
Loratadine—Gastrointestinal pain—Niacin—atherosclerosis	0.000298	0.0035	CcSEcCtD
Loratadine—Nausea—Rosuvastatin—atherosclerosis	0.000297	0.0035	CcSEcCtD
Loratadine—Feeling abnormal—Pravastatin—atherosclerosis	0.000295	0.00348	CcSEcCtD
Loratadine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000293	0.00345	CcSEcCtD
Loratadine—Diarrhoea—Lovastatin—atherosclerosis	0.00029	0.00341	CcSEcCtD
Loratadine—Abdominal pain—Niacin—atherosclerosis	0.000288	0.00339	CcSEcCtD
Loratadine—Body temperature increased—Niacin—atherosclerosis	0.000288	0.00339	CcSEcCtD
Loratadine—Asthenia—Simvastatin—atherosclerosis	0.000285	0.00335	CcSEcCtD
Loratadine—Diarrhoea—Ezetimibe—atherosclerosis	0.000285	0.00335	CcSEcCtD
Loratadine—Abdominal pain—Pravastatin—atherosclerosis	0.000283	0.00333	CcSEcCtD
Loratadine—Body temperature increased—Pravastatin—atherosclerosis	0.000283	0.00333	CcSEcCtD
Loratadine—Dizziness—Lovastatin—atherosclerosis	0.00028	0.0033	CcSEcCtD
Loratadine—Dizziness—Ezetimibe—atherosclerosis	0.000275	0.00323	CcSEcCtD
Loratadine—Diarrhoea—Simvastatin—atherosclerosis	0.000271	0.00319	CcSEcCtD
Loratadine—Vomiting—Lovastatin—atherosclerosis	0.00027	0.00317	CcSEcCtD
Loratadine—Rash—Lovastatin—atherosclerosis	0.000267	0.00314	CcSEcCtD
Loratadine—Dermatitis—Lovastatin—atherosclerosis	0.000267	0.00314	CcSEcCtD
Loratadine—Headache—Lovastatin—atherosclerosis	0.000266	0.00312	CcSEcCtD
Loratadine—Vomiting—Ezetimibe—atherosclerosis	0.000264	0.00311	CcSEcCtD
Loratadine—Dizziness—Simvastatin—atherosclerosis	0.000262	0.00308	CcSEcCtD
Loratadine—Rash—Ezetimibe—atherosclerosis	0.000262	0.00308	CcSEcCtD
Loratadine—Dermatitis—Ezetimibe—atherosclerosis	0.000262	0.00308	CcSEcCtD
Loratadine—Asthenia—Niacin—atherosclerosis	0.000261	0.00307	CcSEcCtD
Loratadine—Headache—Ezetimibe—atherosclerosis	0.000261	0.00306	CcSEcCtD
Loratadine—Asthenia—Pravastatin—atherosclerosis	0.000257	0.00303	CcSEcCtD
Loratadine—Vomiting—Simvastatin—atherosclerosis	0.000252	0.00297	CcSEcCtD
Loratadine—Nausea—Lovastatin—atherosclerosis	0.000252	0.00296	CcSEcCtD
Loratadine—Rash—Simvastatin—atherosclerosis	0.00025	0.00294	CcSEcCtD
Loratadine—Dermatitis—Simvastatin—atherosclerosis	0.00025	0.00294	CcSEcCtD
Loratadine—Diarrhoea—Niacin—atherosclerosis	0.000249	0.00293	CcSEcCtD
Loratadine—Headache—Simvastatin—atherosclerosis	0.000248	0.00292	CcSEcCtD
Loratadine—Nausea—Ezetimibe—atherosclerosis	0.000247	0.00291	CcSEcCtD
Loratadine—Diarrhoea—Pravastatin—atherosclerosis	0.000245	0.00289	CcSEcCtD
Loratadine—Dizziness—Niacin—atherosclerosis	0.000241	0.00283	CcSEcCtD
Loratadine—Dizziness—Pravastatin—atherosclerosis	0.000237	0.00279	CcSEcCtD
Loratadine—Nausea—Simvastatin—atherosclerosis	0.000236	0.00277	CcSEcCtD
Loratadine—Vomiting—Niacin—atherosclerosis	0.000232	0.00272	CcSEcCtD
Loratadine—Rash—Niacin—atherosclerosis	0.00023	0.0027	CcSEcCtD
Loratadine—Dermatitis—Niacin—atherosclerosis	0.000229	0.0027	CcSEcCtD
Loratadine—Headache—Niacin—atherosclerosis	0.000228	0.00268	CcSEcCtD
Loratadine—Vomiting—Pravastatin—atherosclerosis	0.000228	0.00268	CcSEcCtD
Loratadine—Rash—Pravastatin—atherosclerosis	0.000226	0.00266	CcSEcCtD
Loratadine—Dermatitis—Pravastatin—atherosclerosis	0.000226	0.00266	CcSEcCtD
Loratadine—Headache—Pravastatin—atherosclerosis	0.000225	0.00264	CcSEcCtD
Loratadine—Nausea—Niacin—atherosclerosis	0.000216	0.00254	CcSEcCtD
Loratadine—Nausea—Pravastatin—atherosclerosis	0.000213	0.00251	CcSEcCtD
Loratadine—CYP2C8—Metabolism—APOC3—atherosclerosis	7.27e-06	0.000336	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—BGN—atherosclerosis	7.26e-06	0.000335	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOA5—atherosclerosis	7.25e-06	0.000335	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—LDLR—atherosclerosis	7.23e-06	0.000334	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	7.21e-06	0.000333	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PARP1—atherosclerosis	7.19e-06	0.000332	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PLAT—atherosclerosis	7.19e-06	0.000332	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GHRL—atherosclerosis	7.19e-06	0.000332	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOA5—atherosclerosis	7.19e-06	0.000332	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALOX5—atherosclerosis	7.16e-06	0.00033	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CETP—atherosclerosis	7.06e-06	0.000326	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.98e-06	0.000322	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	6.98e-06	0.000322	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	6.92e-06	0.000319	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—F2—atherosclerosis	6.91e-06	0.000319	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.88e-06	0.000318	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.84e-06	0.000316	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.78e-06	0.000313	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.77e-06	0.000312	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.76e-06	0.000312	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—SCARB1—atherosclerosis	6.76e-06	0.000312	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALOX5—atherosclerosis	6.74e-06	0.000311	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALOX5—atherosclerosis	6.68e-06	0.000308	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CG—atherosclerosis	6.61e-06	0.000305	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.58e-06	0.000304	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NAMPT—atherosclerosis	6.58e-06	0.000303	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.54e-06	0.000302	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—LIPC—atherosclerosis	6.53e-06	0.000301	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCG1—atherosclerosis	6.53e-06	0.000301	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—APOC3—atherosclerosis	6.49e-06	0.0003	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—LDLR—atherosclerosis	6.45e-06	0.000298	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NAMPT—atherosclerosis	6.42e-06	0.000296	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—HMGCR—atherosclerosis	6.39e-06	0.000295	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—LIPC—atherosclerosis	6.38e-06	0.000294	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—APOC3—atherosclerosis	6.34e-06	0.000292	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KNG1—atherosclerosis	6.31e-06	0.000291	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CETP—atherosclerosis	6.3e-06	0.000291	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—LDLR—atherosclerosis	6.3e-06	0.000291	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AGTR1—atherosclerosis	6.27e-06	0.00029	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.18e-06	0.000285	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—CCL2—atherosclerosis	6.16e-06	0.000284	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CETP—atherosclerosis	6.15e-06	0.000284	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—FABP4—atherosclerosis	6.14e-06	0.000283	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LCAT—atherosclerosis	6.14e-06	0.000283	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PLG—atherosclerosis	6.12e-06	0.000282	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NAMPT—atherosclerosis	6.05e-06	0.000279	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	6.04e-06	0.000279	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—SCARB1—atherosclerosis	6.04e-06	0.000279	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOA4—atherosclerosis	6.02e-06	0.000278	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—LIPC—atherosclerosis	6.01e-06	0.000277	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NAMPT—atherosclerosis	6e-06	0.000277	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOC3—atherosclerosis	5.97e-06	0.000276	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.96e-06	0.000275	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—LIPC—atherosclerosis	5.96e-06	0.000275	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—LDLR—atherosclerosis	5.94e-06	0.000274	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOC3—atherosclerosis	5.92e-06	0.000273	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	5.92e-06	0.000273	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SCARB1—atherosclerosis	5.89e-06	0.000272	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—LDLR—atherosclerosis	5.88e-06	0.000272	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.88e-06	0.000271	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CETP—atherosclerosis	5.8e-06	0.000268	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SOCS3—atherosclerosis	5.79e-06	0.000267	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.76e-06	0.000266	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CETP—atherosclerosis	5.75e-06	0.000265	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—HMGCR—atherosclerosis	5.7e-06	0.000263	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ABCA1—atherosclerosis	5.69e-06	0.000263	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MMP3—atherosclerosis	5.59e-06	0.000258	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF2—atherosclerosis	5.57e-06	0.000257	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—HMGCR—atherosclerosis	5.56e-06	0.000257	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SCARB1—atherosclerosis	5.55e-06	0.000256	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SCARB1—atherosclerosis	5.5e-06	0.000254	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	5.47e-06	0.000252	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	5.45e-06	0.000252	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APOB—atherosclerosis	5.41e-06	0.000249	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—CXCL8—atherosclerosis	5.36e-06	0.000247	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.36e-06	0.000247	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EDN1—atherosclerosis	5.32e-06	0.000245	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCL5—atherosclerosis	5.28e-06	0.000244	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HMGCR—atherosclerosis	5.24e-06	0.000242	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HMGCR—atherosclerosis	5.2e-06	0.00024	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOA2—atherosclerosis	5.18e-06	0.000239	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	5.18e-06	0.000239	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	5.18e-06	0.000239	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALOX15—atherosclerosis	5.18e-06	0.000239	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—LPL—atherosclerosis	5.16e-06	0.000238	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.14e-06	0.000237	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCG5—atherosclerosis	5.12e-06	0.000236	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ABCA1—atherosclerosis	5.08e-06	0.000234	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PRKCG—atherosclerosis	5.02e-06	0.000232	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ABCA1—atherosclerosis	4.96e-06	0.000229	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LPA—atherosclerosis	4.95e-06	0.000228	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SPP1—atherosclerosis	4.89e-06	0.000226	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—HMOX1—atherosclerosis	4.88e-06	0.000225	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—CXCL8—atherosclerosis	4.87e-06	0.000225	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—BGN—atherosclerosis	4.79e-06	0.000221	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOA5—atherosclerosis	4.74e-06	0.000219	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.69e-06	0.000216	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—APOB—atherosclerosis	4.68e-06	0.000216	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ABCA1—atherosclerosis	4.67e-06	0.000216	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ABCA1—atherosclerosis	4.63e-06	0.000214	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	4.56e-06	0.000211	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTM1—atherosclerosis	4.55e-06	0.00021	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PDGFB—atherosclerosis	4.52e-06	0.000209	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—LPL—atherosclerosis	4.47e-06	0.000206	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AGT—atherosclerosis	4.42e-06	0.000204	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.41e-06	0.000203	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—HMOX1—atherosclerosis	4.36e-06	0.000201	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GPX1—atherosclerosis	4.36e-06	0.000201	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—LEP—atherosclerosis	4.33e-06	0.0002	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APOE—atherosclerosis	4.33e-06	0.0002	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CAV1—atherosclerosis	4.29e-06	0.000198	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APOA1—atherosclerosis	4.28e-06	0.000197	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—HMOX1—atherosclerosis	4.26e-06	0.000196	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CD36—atherosclerosis	4.24e-06	0.000196	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—APOB—atherosclerosis	4.18e-06	0.000193	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ESR1—atherosclerosis	4.13e-06	0.000191	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—F2—atherosclerosis	4.08e-06	0.000188	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—APOB—atherosclerosis	4.08e-06	0.000188	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTM1—atherosclerosis	4.06e-06	0.000187	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—MTHFR—atherosclerosis	4.02e-06	0.000186	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HMOX1—atherosclerosis	4.01e-06	0.000185	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—LPL—atherosclerosis	3.99e-06	0.000184	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HMOX1—atherosclerosis	3.98e-06	0.000183	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTM1—atherosclerosis	3.96e-06	0.000183	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.95e-06	0.000182	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPARA—atherosclerosis	3.95e-06	0.000182	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LIPC—atherosclerosis	3.93e-06	0.000181	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOC3—atherosclerosis	3.9e-06	0.00018	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	3.9e-06	0.00018	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—LPL—atherosclerosis	3.89e-06	0.00018	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GPX1—atherosclerosis	3.89e-06	0.000179	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LDLR—atherosclerosis	3.88e-06	0.000179	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOB—atherosclerosis	3.84e-06	0.000177	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AGT—atherosclerosis	3.82e-06	0.000176	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOB—atherosclerosis	3.81e-06	0.000176	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GPX1—atherosclerosis	3.8e-06	0.000175	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CETP—atherosclerosis	3.79e-06	0.000175	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CD36—atherosclerosis	3.79e-06	0.000175	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—APOE—atherosclerosis	3.74e-06	0.000173	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	3.74e-06	0.000173	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTM1—atherosclerosis	3.74e-06	0.000172	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CAV1—atherosclerosis	3.71e-06	0.000171	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTM1—atherosclerosis	3.7e-06	0.000171	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—APOA1—atherosclerosis	3.7e-06	0.000171	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CD36—atherosclerosis	3.7e-06	0.000171	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—INS—atherosclerosis	3.7e-06	0.000171	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—LPL—atherosclerosis	3.67e-06	0.000169	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCL2—atherosclerosis	3.64e-06	0.000168	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—LPL—atherosclerosis	3.64e-06	0.000168	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.63e-06	0.000167	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—MTHFR—atherosclerosis	3.59e-06	0.000166	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GPX1—atherosclerosis	3.58e-06	0.000165	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF1—atherosclerosis	3.58e-06	0.000165	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GPX1—atherosclerosis	3.55e-06	0.000164	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPARA—atherosclerosis	3.52e-06	0.000163	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—MTHFR—atherosclerosis	3.5e-06	0.000162	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CD36—atherosclerosis	3.48e-06	0.000161	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CD36—atherosclerosis	3.45e-06	0.000159	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPARA—atherosclerosis	3.44e-06	0.000159	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.43e-06	0.000158	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AGT—atherosclerosis	3.41e-06	0.000157	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	3.39e-06	0.000157	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CG—atherosclerosis	3.38e-06	0.000156	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—APOE—atherosclerosis	3.34e-06	0.000154	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AGT—atherosclerosis	3.33e-06	0.000154	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CAV1—atherosclerosis	3.31e-06	0.000153	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—APOA1—atherosclerosis	3.3e-06	0.000152	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—MTHFR—atherosclerosis	3.3e-06	0.000152	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—MTHFR—atherosclerosis	3.27e-06	0.000151	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—APOE—atherosclerosis	3.26e-06	0.000151	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPARG—atherosclerosis	3.26e-06	0.00015	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOS3—atherosclerosis	3.24e-06	0.00015	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPARA—atherosclerosis	3.24e-06	0.000149	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CAV1—atherosclerosis	3.23e-06	0.000149	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—APOA1—atherosclerosis	3.22e-06	0.000149	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPARA—atherosclerosis	3.21e-06	0.000148	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—INS—atherosclerosis	3.2e-06	0.000148	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AGT—atherosclerosis	3.14e-06	0.000145	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AGT—atherosclerosis	3.11e-06	0.000144	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOE—atherosclerosis	3.07e-06	0.000142	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.06e-06	0.000141	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOE—atherosclerosis	3.05e-06	0.000141	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CAV1—atherosclerosis	3.05e-06	0.000141	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOA1—atherosclerosis	3.04e-06	0.00014	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CAV1—atherosclerosis	3.02e-06	0.000139	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	3.02e-06	0.000139	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOA1—atherosclerosis	3.01e-06	0.000139	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.94e-06	0.000136	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ALB—atherosclerosis	2.93e-06	0.000135	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPARG—atherosclerosis	2.91e-06	0.000134	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	2.88e-06	0.000133	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—INS—atherosclerosis	2.86e-06	0.000132	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPARG—atherosclerosis	2.84e-06	0.000131	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NOS3—atherosclerosis	2.81e-06	0.000129	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—INS—atherosclerosis	2.79e-06	0.000129	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	2.78e-06	0.000128	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	2.77e-06	0.000128	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.75e-06	0.000127	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL6—atherosclerosis	2.73e-06	0.000126	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPARG—atherosclerosis	2.68e-06	0.000124	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPARG—atherosclerosis	2.65e-06	0.000122	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—INS—atherosclerosis	2.63e-06	0.000121	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.62e-06	0.000121	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALB—atherosclerosis	2.62e-06	0.000121	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—INS—atherosclerosis	2.6e-06	0.00012	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MMP9—atherosclerosis	2.6e-06	0.00012	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	2.57e-06	0.000119	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.57e-06	0.000118	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALB—atherosclerosis	2.55e-06	0.000118	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	2.53e-06	0.000117	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	2.52e-06	0.000116	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOB—atherosclerosis	2.51e-06	0.000116	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NOS3—atherosclerosis	2.5e-06	0.000116	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NOS3—atherosclerosis	2.44e-06	0.000113	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.44e-06	0.000113	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALB—atherosclerosis	2.41e-06	0.000111	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LPL—atherosclerosis	2.4e-06	0.000111	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALB—atherosclerosis	2.39e-06	0.00011	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GPX1—atherosclerosis	2.34e-06	0.000108	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	2.34e-06	0.000108	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—STAT3—atherosclerosis	2.31e-06	0.000107	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NOS3—atherosclerosis	2.3e-06	0.000106	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS2—atherosclerosis	2.29e-06	0.000106	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NOS3—atherosclerosis	2.28e-06	0.000105	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CD36—atherosclerosis	2.28e-06	0.000105	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS2—atherosclerosis	2.24e-06	0.000103	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	2.21e-06	0.000102	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.16e-06	9.96e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	2.14e-06	9.89e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPARA—atherosclerosis	2.12e-06	9.77e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.11e-06	9.72e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.09e-06	9.63e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AGT—atherosclerosis	2.05e-06	9.46e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOE—atherosclerosis	2.01e-06	9.27e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CAV1—atherosclerosis	1.99e-06	9.19e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOA1—atherosclerosis	1.99e-06	9.17e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.81e-06	8.37e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.75e-06	8.08e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—INS—atherosclerosis	1.72e-06	7.92e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6—atherosclerosis	1.62e-06	7.45e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALB—atherosclerosis	1.57e-06	7.26e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.51e-06	6.95e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.49e-06	6.87e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.38e-06	6.35e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AKT1—atherosclerosis	1.29e-06	5.95e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKT1—atherosclerosis	1.15e-06	5.31e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKT1—atherosclerosis	1.12e-06	5.18e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.06e-06	4.88e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKT1—atherosclerosis	1.05e-06	4.84e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKT1—atherosclerosis	6.92e-07	3.19e-05	CbGpPWpGaD
